We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
Turnover
16.91%
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+9.68%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$9.62M
(+7.4%)
Cap. Flow
+$2.42M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
27.84%
Holding
157
New
14
Increased
39
Reduced
52
Closed
19
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$2.49M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.34M |
| 3 |
GEN MOTORS CORP
GM
|
+$2.05M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.37M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$1.98M |
| 2 |
Howard Hughes
HHH
|
+$1.7M |
| 3 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$1.39M |
| 4 |
Newmont
NEM
|
+$860K |
| 5 |
Corning
GLW
|
+$834K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.67% |
| 2 | Energy | 14.21% |
| 3 | Technology | 10.78% |
| 4 | Healthcare | 9.81% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AVG
101
DELISTED
AVG Technologies N.V.
AVG
| $215K | 0.15% |
9,000
-16,000
| -64% | -$356K |
2013 Q2
1 quarter
|
|
|
BSJF
102
DELISTED
GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF
BSJF
| $214K | 0.15% |
8,000
| – | – |
2013 Q2
1 quarter
|
|
103
IBM
IBM
$218B
| $207K | 0.15% |
1,172
-1,098
| -48% | -$200K |
2013 Q2
1 quarter
|
|
104
abrdn Asia-Pacific Income Fund
FAX
$530M
| $174K | 0.12% |
4,783
-167
| -3% | -$6.11K |
2013 Q2
1 quarter
|
|
|
PWE
105
DELISTED
Penn West Energy Petroleum Ltd
PWE
| $144K | 0.1% |
13,015
-7,630
| -37% | -$88.5K |
2013 Q2
1 quarter
|
|
106
PCM Fund
PCM
$61.2M
| $142K | 0.1% |
12,400
| – | – |
2013 Q2
1 quarter
|
|
107
Capital Clean Energy Carriers
CCEC
$1.21B
| $136K | 0.1% |
2,151
-5,300
| -71% | -$343K |
2013 Q2
1 quarter
|
|
108
Rambus
RMBS
$9.76B
| $117K | 0.08% |
12,500
-7,500
| -38% | -$68.7K |
2013 Q2
1 quarter
|
|
109
DELISTED
Denny's
DENN
| $113K | 0.08% |
18,500
-20,000
| -52% | -$117K |
2013 Q2
1 quarter
|
|
|
PDL.B
110
DELISTED
PRESIDENTAL RLTY CL B
PDL.B
| $91K | 0.07% |
302,922
| – | – |
2013 Q2
1 quarter
|
|
|
ARTX
111
DELISTED
Arotech Corporation
ARTX
| $87K | 0.06% |
+50,000
| New | +$85.5K |
2013 Q3
0 quarters
|
|
112
Reading International Class A
RDI
$40.5M
| $78K | 0.06% |
11,900
| – | – |
2013 Q2
1 quarter
|
|
|
DARA
113
DELISTED
DARA BIOSCIENCES INC COM STK (DE)
DARA
| $64K | 0.05% |
26,100
| – | – |
2013 Q2
1 quarter
|
|
|
ATNY
114
DELISTED
API TECHNOLOGIES CORP. COMMON STOCK
ATNY
| $57K | 0.04% |
+19,500
| New | +$56.6K |
2013 Q3
0 quarters
|
|
|
115
Corning
GLW
$116B
| – | – |
-58,600
| Closed | -$834K | – |
|
116
iShares Dow Jones US ETF
IYY
$3.02B
| – | – |
-11,400
| Closed | -$460K | – |
|
|
117
Ligand Pharmaceuticals
LGND
$5.89B
| – | – |
-84,799
| Closed | -$1.98M | – |
|
|
118
Newmont
NEM
$125B
| – | – |
-28,700
| Closed | -$860K | – |
|
119
RTX Corp
RTX
$258B
| – | – |
-8,739
| Closed | -$511K | – |
|
120
Teekay Tankers
TNK
$3.41B
| – | – |
-1,438
| Closed | -$30K | – |
|
|
TWO
121
DELISTED
Two Harbors Investment
TWO
| – | – |
-1,875
| Closed | -$154K | – |
|
122
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$249M
| – | – |
0
| – | -$394K |
2013 Q2
1 quarter
|
|
123
Visteon
VC
$2.38B
| – | – |
-4,500
| Closed | -$284K | – |
|
124
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| – | – |
-6,800
| Closed | -$324K | – |
|
125
The Gap Inc
GAP
$8.32B
| – | – |
-8,700
| Closed | -$363K | – |
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Benchmark Capital Advisors held 157 positions worth $139M, up 7.4% from $130M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Benchmark Capital Advisors's Q3 2013 filing shows 14 new, 39 increased, 52 reduced and 19 closed positions. Its largest new stake was Bristol-Myers Squibb: 53,400 shares worth $2.47M. The largest sale was Ligand Pharmaceuticals, an estimated $1.98M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 24% a quarter earlier, followed by Energy and Technology.
- Benchmark Capital Advisors's largest Q3 2013 buy was Bristol-Myers Squibb: 53,400 shares worth $2.47M.
- Benchmark Capital Advisors added most to Vodafone in Q3 2013, an estimated $2.49M increase.
- Benchmark Capital Advisors's biggest Q3 2013 reduction was Howard Hughes, cutting an estimated $1.7M.
- Benchmark Capital Advisors fully exited Ligand Pharmaceuticals in Q3 2013, selling an estimated $1.98M.
- Benchmark Capital Advisors's ten largest holdings make up 28% of its $139M portfolio in Q3 2013.
- Benchmark Capital Advisors opened 14 new positions and closed 19 in Q3 2013.
- Benchmark Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $139M.
Based on Benchmark Capital Advisors's 13F filing for Q3 2013, filed 23 Oct 2013.